NEW YORK (GenomeWeb) – Scientists at The Scripps Research Institute will use a $2.3 million grant from the National Institute of General Medical Sciences to study protein biomarkers that they may eventually use in tests to diagnose cancer, rheumatoid arthritis, and colitis, TRSI said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.